Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SGMT
#3054
Sagimet Biosciences Inc. Series A Common Stock
5.7
1
-1.04%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-1.04%
Monthly Change
-6.55%
6 month change
-26.04%
Cambio anual
+58.17%
Cierres anteriores
5.7
7
Open
5.7
1
Bid
Ask
Low
5.7
1
High
5.7
1
Volumen
21
Markets
Acciones
Atención Sanitaria
SGMT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
30.67 M
32.2 M
32.2 M
32.52 M
32.52 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
0.04
-3.1
-1.81
-4.05
-3.79
-12.76
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
1.65
3.32
2.05
4.5
4.9
14.78
Price to book ratio
0.11
0.91
0.16
0.41
0.4
1.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.08
-0.1
-0.12
-0.08
-0.1
-0.4
Return on equity %
-0.09
-0.1
-0.13
-0.08
-0.11
-0.42
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
39.43
34.3
20.41
17.55
13.06
85.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.63
-0.35
-0.45
-0.28
-0.32
-1.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.48
5.06
4.49
4.21
3.89
17.65
Net current asset value per share
5.06
4.87
4.54
3.95
3.7
17.06
Tangible book value per share
5.5
4.97
4.32
4.04
3.69
17.02
Working capital per share
4.94
4.73
4.31
3.73
3.42
16.19
Book value per share
5.5
4.97
4.32
4.04
3.69
17.02
Noticias
Акции Sagimet растут после положительных данных о безопасности препарата от акне
Sagimet stock rises after positive Phase 3 safety data for acne drug
Ascletis сообщает положительные данные о безопасности препарата от акне
Ascletis reports positive long-term safety data for acne drug denifanstat
Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market (SGMT)
Sagimet сообщает о положительных результатах фазы 1 для комбинированной терапии MASH
Sagimet reports positive Phase 1 results for MASH combination therapy
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Sagimet Biosciences executive chairman sells $290k in shares
Citizens повысил целевую цену акций Sagimet Biosciences до $35
Sagimet Biosciences stock price target raised to $35 by Citizens
Денифанстат успешно прошел все этапы испытаний при акне в Китае